Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris
- 1 December 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 52 (6) , 754-761
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicansInternational Journal of Antimicrobial Agents, 2013
- Targeting Listeria Monocytogenes rpoA and rpoD Genes Using Peptide Nucleic AcidsNucleic Acid Therapeutics, 2013
- Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicansPLOS ONE, 2013
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida aurisJournal of Clinical Microbiology, 2011
- Problems and hopes in the development of drugs targeting the fungal cell wallExpert Review of Anti-infective Therapy, 2010
- Candida albicans Hyphal Formation and Virulence Assessed Using a Caenorhabditis elegans Infection ModelEukaryotic Cell, 2009
- Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1pAnalytical Biochemistry, 2009
- Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans AssayPLOS ONE, 2009
- Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicansJournal of Antimicrobial Chemotherapy, 2006